Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH), 41446-41447 [E9-19701]
Download as PDF
<![CDATA[
41446
Federal Register / Vol. 74, No. 157 / Monday, August 17, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSKH9S0YB1PROD with NOTICES
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92–463,
notice is hereby given of the twentieth
meeting of the Secretary’s Advisory
Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health
Service. The meeting will be held from
8:30 a.m. to approximately 6 p.m. on
Thursday, October 8, 2009, and from 8
a.m. to approximately 3:30 p.m. on
Friday, October 9, 2009, at the Hubert H.
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201.
The meeting will be open to the public
with attendance limited to space
available. The meeting also will be Web
cast.
The main agenda items involve the
review of three SACGHS draft reports: a
final draft report and its
recommendations on gene patents and
licensing practices along with
comments received on the public
consultation draft circulated earlier this
year; a public consultation draft report
on genetics education and training; and
a revised draft paper on direct-toconsumer genetic testing. The first day
of the meeting will include an extended
period of time for interested members of
the public to provide their perspectives
on gene patents and licensing practices
and their effect on patient access to
genetic tests. Members of the public are
encouraged to contact the SACGHS
Executive Secretary (see below) by
September 15, 2009, if they wish to
participate in this extended public
comment period. Other agenda items
include an update on regulations
implementing the Genetic Information
Nondiscrimination Act, a report on
activities of the Clinical Utility and
Comparative Effectiveness Task Force,
and a brief discussion to initiate the
Committee’s work on ethical issues
related to genomic data sharing.
As always, the Committee welcomes
hearing from anyone wishing to provide
public comment on any issue related to
genetics, health and society. Individuals
who would like to provide public
comment should notify the SACGHS
Executive Secretary, Ms. Sarah Carr, by
telephone at 301–496–9838 or e-mail at
carrs@od.nih.gov. The SACGHS office is
located at 6705 Rockledge Drive, Suite
750, Bethesda, MD 20892. Anyone
planning to attend the meeting who
needs special assistance, such as sign
language interpretation or other
VerDate Nov<24>2008
17:55 Aug 14, 2009
Jkt 217001
reasonable accommodations, is also
asked to contact the Executive
Secretary.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
and genomic technologies and, as
warranted, to provide advice on these
issues. The draft meeting agenda and
other information about SACGHS,
including information about access to
the Web cast, will be available at the
following Web site: https://
oba.od.nih.gov/SACGHS/
sacghs_meetings.html.
Dated: August 10, 2009.
Jennifer Spaeth,
Director, NIH Office of Federal Advisory
Committee Policy.
[FR Doc. E9–19583 Filed 8–14–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Neurological
Disorders and Stroke Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: September 17–18, 2009.
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Open: September 17, 2009, 10:30 a.m. to
5:00 p.m.
Agenda: Report by the Director, NINDS;
Report by the Associate Director for
Extramural Research and other
Administrative and Program Developments.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Closed: September 18, 2009, 8 a.m. to 11:30
a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, PhD,
Associate Director for Extramural Research,
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: August 10, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–19578 Filed 8–14–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
E:\FR\FM\17AUN1.SGM
17AUN1
Federal Register / Vol. 74, No. 157 / Monday, August 17, 2009 / Notices
mstockstill on DSKH9S0YB1PROD with NOTICES
Control and Prevention, announces the
following meeting for the
aforementioned subcommittee:
Time and Date: 10 a.m.–5 p.m., September
3, 2009.
Place: Cincinnati Airport Marriott, 2395
Progress Drive, Hebron, Kentucky 41018.
Telephone (859) 334–4611, Fax (859) 334–
4619.
Status: Open to the public, but without a
public comment period. To access by
conference call dial the following
information 1(866) 659–0537, Participant
Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2011.
Purpose: The Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee for Dose
Reconstruction Reviews was established to
aid the Advisory Board in carrying out its
duty to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Discussed: The agenda for
the Subcommittee meeting includes:
Discussion of dose reconstruction cases
under review; OCAS dose reconstruction
quality management and assurance activities;
selection of an additional set of cases for
review.
In the event an individual cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
VerDate Nov<24>2008
17:55 Aug 14, 2009
Jkt 217001
the contact person below well in advance of
the meeting.
For More Information Contact: Theodore
Katz, Executive Secretary, NIOSH, CDC, 1600
Clifton Road, Mailstop E–20, Atlanta GA
30333, Telephone (513) 533–6800, Toll Free
1(800) CDC–INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: August 10, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–19701 Filed 8–14–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director,
Centers for Disease Control and
Prevention (ACD, CDC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following Meeting of the
aforementioned committee:
Time and Date: 4:30 p.m.–6 p.m.,
September 1, 2009.
Place: The teleconference call will
originate at the Centers for Disease Control
and Prevention in Atlanta, Georgia. Please
see Supplementary Information for details on
accessing the teleconference.
Status: Open to the public, teleconference
access limited only by availability of
telephone ports.
Purpose: The committee will provide
advice to the CDC Director on strategic and
other broad issues facing CDC.
Matters To Be Discussed: The committee
will discuss and decide on recommendations
from its Ethics Subcommittee, National
Biosurveillance Advisory Subcommittee, and
the Health Disparities Subcommittee. The
Ethics Subcommittee will make
recommendations on using travel restrictions
for individuals with infectious illnesses; and
discuss a draft charge that clearly articulates
the ethical foundation for focusing on health
protection activities and examining the social
determinants of health. The National
Biosurveillance Advisory Subcommittee will
present their final report on biosurveillance
recommendations. The Health Disparities
Subcommittee will present their mission.
The ACD, CDC will also receive an update on
H1N1 and the plans for the upcoming flu
season.
Agenda items are subject to change as
priorities dictate.
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
41447
Supplementary Information: This
conference call is scheduled to begin at 4:30
p.m. To participate in the teleconference,
please dial 1–800–593–9961 and enter
conference code 3699611. You will then be
automatically connected to the call.
Contact Person for More Information: Anne
Haddix, M.D., Designated Federal Officer,
Advisory Committee to the Director, CDC,
1600 Clifton Road, NE., M/S D–14, Atlanta,
Georgia 30333. Telephone 404–639–0663.
The Director, Management Analysis and
Services office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: August 10, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. E9–19698 Filed 8–14–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center on Minority Health and
Health Disparities; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council on Minority
Health and Health Disparities.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Minority Health and Health
Disparities; NACMHD
Date: September 8, 2009
Closed: 8 a.m. to 10 a.m.
E:\FR\FM\17AUN1.SGM
17AUN1
]]>Agencies
[Federal Register Volume 74, Number 157 (Monday, August 17, 2009)]
[Notices]
[Pages 41446-41447]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-19701]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH), National Institute for
Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease
[[Page 41447]]
Control and Prevention, announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10 a.m.-5 p.m., September 3, 2009.
Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron,
Kentucky 41018. Telephone (859) 334-4611, Fax (859) 334-4619.
Status: Open to the public, but without a public comment period.
To access by conference call dial the following information 1(866)
659-0537, Participant Pass Code 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing
advice on the development of probability of causation guidelines
that have been promulgated by the Department of Health and Human
Services (HHS) as a final rule; advice on methods of dose
reconstruction which have also been promulgated by HHS as a final
rule; advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program; and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2011.
Purpose: The Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class. The Subcommittee for Dose Reconstruction Reviews was
established to aid the Advisory Board in carrying out its duty to
advise the Secretary, HHS, on dose reconstruction.
Matters To Be Discussed: The agenda for the Subcommittee meeting
includes: Discussion of dose reconstruction cases under review; OCAS
dose reconstruction quality management and assurance activities;
selection of an additional set of cases for review.
In the event an individual cannot attend, written comments may
be submitted. Any written comments received will be provided at the
meeting and should be submitted to the contact person below well in
advance of the meeting.
For More Information Contact: Theodore Katz, Executive
Secretary, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta GA
30333, Telephone (513) 533-6800, Toll Free 1(800) CDC-INFO, E-mail
ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: August 10, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-19701 Filed 8-14-09; 8:45 am]
BILLING CODE 4163-18-P
